Lukas Biomedical Inc. (TPEX:6814)
Taiwan · Delayed Price · Currency is TWD 28.20
-0.10 (-0.35%)
At close: Feb 11, 2026
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 1.18 billion as of February 11, 2026. Its market cap has increased by 2.17% in one year.
Market Cap
1.18B
Enterprise Value
1.28B
Revenue
180.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.20
Market Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 1.18B, a decrease of -33.48%. That is a compound annual growth rate of -7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.18B | -9.03% |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Great Novel Therapeutics Biotech & Medicals | 1.46B |
| Enimmune | 1.43B |
| Meribank Biotech | 1.32B |
| GeneReach Biotechnology | 1.20B |
| Neith | 1.15B |
| Holy Stone Healthcare | 1.13B |
| Level Biotechnology | 1.07B |
| TCI GENE | 1.01B |